HCA Healthcare Fraud Settlement (2000)
Few cases better illustrate the scale of healthcare fraud than the qui tam action against HCA Healthcare. That case ultimately settled in 2000 and marked a major achievement in federal FCA enforcement.
The case stemmed from widespread allegations that HCA, one of the largest hospital chains in the U.S., engaged in fraudulent billing practices. The company was accused of overcharging federal healthcare programs, billing for unnecessary lab tests, and paying kickbacks to physicians for patient referrals.
After years of investigation, HCA agreed to pay more than $1.7 billion in criminal fines and civil penalties—the largest healthcare fraud settlement in U.S. history at that time. Multiple whistleblowers played key roles in uncovering the misconduct, bringing qui tam actions under the False Claims Act.
The HCA case was transformative. It set new expectations for corporate accountability in healthcare and showed that even industry leaders are not immune from scrutiny. It also demonstrated that nine- and ten-figure settlements were not just possible in the pharmaceutical industry, which is where most of the biggest FCA settlements and judgments had come from prior to that point.
The HCA case was a turning point that demonstrated the power of truth-tellers and the long-term value of the False Claims Act.
The government accused HCA of systematically defrauding federal healthcare programs through a variety of billing schemes. The allegations painted a picture of a company that prioritized profits over compliance.
– HCA was accused of overcharging Medicare and other federal programs for services, including billing for unnecessary lab tests that patients did not need
– The company also faced allegations of paying kickbacks to physicians in exchange for patient referrals, a practice that corrupts medical decision making
– These practices resulted in the submission of false claims to the government, making them actionable under the False Claims Act
The HCA settlement was structured as two separate agreements announced months apart. The combined total came to approximately $840 million in that initial phase.
– The criminal component was $95 million in criminal fines, paid by two HCA subsidiaries that pleaded guilty to defrauding federal healthcare programs
– The civil component was $745 million in civil penalties and damages to resolve False Claims Act allegations for false billing practices
When combined with a later $631 million settlement in 2003 resolving additional whistleblower lawsuits, the total reached $1.7 billion.
Multiple whistleblowers were essential to building the HCA case. Their insider knowledge and willingness to come forward gave the government the evidence it needed to pursue a years-long investigation.
– A financial officer, James Alderson, was fired for refusing to file fraudulent cost reports. He filed a qui tam lawsuit in 1993 that became the flashpoint for the entire investigation
– John Schilling, a former HCA manager in Florida, filed another crucial qui tam lawsuit exposing cost-reporting fraud
– Two Utah emergency room doctors, Robert Rothfeder and Dennis Wyman, filed suit after discovering the chain was billing for unnecessary blood tests.
– In total, at least 29 whistleblowers were publicly identified, with eight separate qui tam lawsuits consolidated into the final settlement.
HCA employed several deceptive practices to maximize reimbursements from federal healthcare programs. The fraud centered on manipulating cost reports and billing for unnecessary services.
– The company allegedly shifted costs between departments to inflate Medicare reimbursement rates, a practice known as cost-shifting
– HCA billed for blood tests that were not ordered by physicians and for other lab services that were medically unnecessary
– The company also paid kickbacks to physicians in exchange for patient referrals to HCA-owned hospitals and clinics
These practices collectively resulted in hundreds of millions in false claims submitted to Medicare and Medicaid.
The HCA case transformed healthcare industry accountability by demonstrating that even the largest hospital chain could face severe consequences for systemic fraud. It forced the industry to take compliance seriously.
– The settlement prompted widespread adoption of corporate integrity agreements, with HCA subject to one of the most rigorous compliance programs ever imposed
– The case encouraged other whistleblowers to come forward, leading to a cascade of healthcare fraud investigations and recoveries in the following years
– It established that cost-reporting fraud and kickback schemes would be aggressively pursued, setting a precedent for future hospital and healthcare system cases
The whistleblowers took significant personal and professional risks to expose HCA’s fraud. They documented misconduct internally, preserved evidence, and ultimately filed qui tam lawsuits that launched the government investigation.
– James Alderson, a financial officer, was fired after refusing to file fraudulent cost reports. He then filed the first qui tam suit in 1993
– John Schilling, a former HCA manager, gathered internal documents showing systematic cost-reporting fraud and filed his own lawsuit
– The two Utah doctors, Rothfeder and Wyman, tracked billing records that revealed HCA was charging for blood tests never ordered by physicians. They preserved this evidence and filed suit.
These coordinated actions gave the government the evidence needed to build its case.
The HCA settlement is a turning point because it was the largest healthcare fraud settlement in U.S. history at the time and demonstrated the power of coordinated whistleblower lawsuits.
The case proved that multiple relators could work together to expose systemic fraud across a massive hospital chain. It also established that the Department of Justice would pursue fraud aggressively, even against the largest healthcare corporations.
The rigorous Corporate Integrity Agreement imposed on HCA became a model for future hospital cases. This settlement further solidified the False Claims Act as the government’s primary weapon against healthcare fraud.
